The effects of a reactivation programme for patients with both COPD and heart failure on exercise capacity and quality of life, a pilot study

Completed

• Conditions: 10019280; 10038716; COPD; heart failure

• Registration Number: NL-OMON32830
• Lead Sponsor: Medisch Spectrum Twente

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 9

Inclusion Criteria

Patient between 40 and 75 years with COPD (GOLD II-III) and heart failure (NHYA II-III)

Exclusion Criteria

Other serious diseases, diseases which serieus influence the ability to walk

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary outcome measure is exercise capacity, measured with the six minute<br /><br>walking test. . </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary outcome measure is health related quality of life measured with<br /><br>disease specific and generic questionnaires</p><br>